Michael Brian Colvin

US Patent:

20220257956, Aug 18, 2022

Filed:

May 9, 2022

Appl. No.:

17/739748

Inventors:

- Brooklyn Park MN, US
Kenneth Lyle Reed - Dallas TX, US
Robert Raymond Bulger - Dallas TX, US
Claire Denault - Dallas TX, US
Michael Steven Colvin - Newbury Park CA, US
Paul Griffith - Brooklyn Park MN, US
Francis Menezes - Simi Valley CA, US

International Classification:

A61N 1/378
A61N 1/372
A61N 1/05
A61N 1/375
A61N 1/36

Abstract:

A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.

US Patent:

20210046319, Feb 18, 2021

Filed:

Oct 30, 2020

Appl. No.:

17/085434

Inventors:

- Santa Clara CA, US
Robert Raymond Bulger - Dallas TX, US
Michael Steven Colvin - Newbury Park CA, US
Claire Denault - Dallas TX, US

International Classification:

A61N 1/378
A61N 1/372
A61N 1/05
A61N 1/375
A61N 1/36

Abstract:

A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.

US Patent:

20200289833, Sep 17, 2020

Filed:

May 29, 2020

Appl. No.:

16/887498

Inventors:

- Santa Clara CA, US
Kenneth Lyle Reed - Dallas TX, US
Robert Raymond Bulger - Dallas TX, US
Claire Denault - Dallas TX, US
Michael Steven Colvin - Newbury Park CA, US
Paul Griffith - Santa Rosa Valley CA, US
Francis Menezes - Simi Valley CA, US

International Classification:

A61N 1/378
A61N 1/372
A61N 1/05
A61N 1/375
A61N 1/36

Abstract:

A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.

US Patent:

20180236245, Aug 23, 2018

Filed:

Feb 9, 2018

Appl. No.:

15/892605

Inventors:

- Southlake TX, US
KENNETH LYLE REED - DALLAS TX, US
ROBERT RAYMOND BULGER - DALLAS TX, US
CLAIRE DENAULT - SOUTHLAKE TX, US
MICHAEL STEVEN COLVIN - NEWBURY PARK CA, US
PAUL GRIFFITH - SANTA ROSA VALLEY CA, US
FRANCIS MENEZES - SIMI VALLEY CA, US

International Classification:

A61N 1/378
A61N 1/05
A61N 1/372
A61N 1/36
A61N 1/375

Abstract:

A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.

US Patent:

20180221664, Aug 9, 2018

Filed:

Feb 6, 2018

Appl. No.:

15/890020

Inventors:

- Southlake TX, US
ROBERT RAYMOND BULGER - DALLAS TX, US
MICHAEL STEVEN COLVIN - NEWBURY PARK CA, US
CLAIRE DENAULT - DALLAS TX, US

International Classification:

A61N 1/36
A61N 1/05

Abstract:

A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.

US Patent:

20170252568, Sep 7, 2017

Filed:

May 18, 2017

Appl. No.:

15/599206

Inventors:

- SOUTHLAKE TX, US
ROBERT RAYMOND BULGER - DALLAS TX, US
MICHAEL STEVEN COLVIN - NEWBURY PARK CA, US

International Classification:

A61N 1/378
A61N 1/372
A61N 1/36
A61N 1/05

Abstract:

A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.

US Patent:

20170113054, Apr 27, 2017

Filed:

Jan 9, 2017

Appl. No.:

15/402090

Inventors:

- Southlake TX, US
KENNETH LYLE REED - Dallas TX, US
ROBERT RAYMOND BULGER - Dallas TX, US
CLAIRE DENAULT - Southlake TX, US
MICHAEL STEVEN COLVIN - Newbury Park CA, US
PAUL GRIFFITH - Santa Rosa Valley CA, US
FRANCIS MENEZES - Simi Valley CA, US

International Classification:

A61N 1/378
A61N 1/05
A61N 1/36
A61N 1/372

Abstract:

A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.

US Patent:

20160331953, Nov 17, 2016

Filed:

Jul 28, 2016

Appl. No.:

15/222821

Inventors:

- Dallas TX, US
ROBERT RAYMOND BULGER - Dallas TX, US
MICHAEL STEVEN COLVIN - Newbury Park CA, US
CLAIRE DENAULT - Dallas TX, US

International Classification:

A61N 1/05
A61N 1/36

Abstract:

An implantable peripheral neurostimulation lead for head pain is adapted for implantation in the head for the therapeutic purpose of treating chronic head and/or face pain. The lead may include a lead body, a plurality of internal electrically conducting metal wires individually connecting to a proximal surface contact and a distal surface electrode; a distal extended metal surface electrode array; and a proximal in-line connector. The lead may be operable to provide medically acceptable therapeutic neurostimulation to multiple regions of the head, including the frontal, parietal, and occipital regions of the head simultaneously. The lead may include a supraorbital electrode array with electrodes of 3 to 5 mm in length spaced apart at 4 to 6 mm intervals. The lead may also include a temporal electrode array with electrodes of 4 to 6 mm in length spaced apart at 8 to 12 mm intervals.